Aurisco Pharmaceutical (605116.SH): Doravirine sodium tablets obtain drug registration approval.
Aurit (605116.SH) announced that recently, the company has received the approval and issuance of the Drug Registration Certificate for Darunavir Sodium Tablets by the National Medical Products Administration. Darunavir Sodium Tablets are indicated for use in combination with other antiretroviral drugs for the treatment of HIV infection in adult patients and children aged 12 and older.
Aurisco Pharmaceutical (605116.SH) announced that it has recently received the Drug Registration Certificate for Doravirine Sodium Tablets issued by the National Medical Products Administration. Doravirine Sodium Tablets are indicated for use with other antiretroviral drugs for the treatment of HIV infection in adults and children aged 12 and older.
Related Articles
VICTORY SEC (08540) plans to adopt a new share plan and terminate the existing share plan.
LANCANG TEA (06911) provides guarantees for its subsidiary company to arrange a credit agreement.
.png)
COUNTRY GARDEN (02007) issued a total of 147 million shares of mandatory convertible bonds with zero coupon that were converted.
VICTORY SEC (08540) plans to adopt a new share plan and terminate the existing share plan.
LANCANG TEA (06911) provides guarantees for its subsidiary company to arrange a credit agreement.
COUNTRY GARDEN (02007) issued a total of 147 million shares of mandatory convertible bonds with zero coupon that were converted.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
